149 related articles for article (PubMed ID: 11419670)
1. Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. Introduction.
Craig WA
Respir Med; 2001 Jun; 95 Suppl A():S2-4; discussion S26-7. PubMed ID: 11419670
[No Abstract] [Full Text] [Related]
2. Respiratory tract infection: epidemiology and surveillance.
Jacobs MR
J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
[TBL] [Abstract][Full Text] [Related]
3. [Amoxicillin/clavulanic acid (875/125 mg). New pharmacodynamic aspects].
Lode H
Dtsch Med Wochenschr; 1999 Dec; 124(48):1459-61. PubMed ID: 10615328
[No Abstract] [Full Text] [Related]
4. Antibiotic resistance. Epidemiology of resistance--respiratory tract infections.
Thomson CJ
J Med Microbiol; 1997 Jun; 46(6):442-5. PubMed ID: 9379469
[No Abstract] [Full Text] [Related]
5. Basing empiric treatment choices for respiratory tract infection on the results of the Alexander Project.
Garau J
J Chemother; 1999 Feb; 11 Suppl 1():51-5. PubMed ID: 10207774
[TBL] [Abstract][Full Text] [Related]
6. Microbiology of bacterial respiratory infections.
Cappelletty D
Pediatr Infect Dis J; 1998 Aug; 17(8 Suppl):S55-61. PubMed ID: 9727651
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of oral cephalosporins in upper respiratory tract infections.
Negri MC; Morosini MI; Loza E; Baquero F
Clin Microbiol Infect; 2000; 6 Suppl 3():56-8. PubMed ID: 11449653
[No Abstract] [Full Text] [Related]
8. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.
Felmingham D; Washington J
J Chemother; 1999 Feb; 11 Suppl 1():5-21. PubMed ID: 10207769
[TBL] [Abstract][Full Text] [Related]
9. Lower respiratory tract infection therapy--the role of ciprofloxacin.
Ball AP; Tillotson GS
J Int Med Res; 1995; 23(5):315-27. PubMed ID: 8529774
[TBL] [Abstract][Full Text] [Related]
10. The incidence of respiratory tract pathogens and antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated between 1990 and 1993.
Nishioka K; Ogihara H; Ohno I; Tanno Y; Shirato K
Tohoku J Exp Med; 1996 Jun; 179(2):111-21. PubMed ID: 8875767
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study.
Thornsberry C; Sahm DF
Chemotherapy; 2000; 46 Suppl 1():15-23. PubMed ID: 10810209
[TBL] [Abstract][Full Text] [Related]
12. Bacterial infection in chronic obstructive pulmonary disease.
Murphy TF; Sethi S
Am Rev Respir Dis; 1992 Oct; 146(4):1067-83. PubMed ID: 1416398
[No Abstract] [Full Text] [Related]
13. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
Soriano F; Fernández-Roblas R
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
[No Abstract] [Full Text] [Related]
14. Significance, isolation, identification and sensitivity of Branhaemella (moraxella) catarrhalis.
Hafiz S; Hafiz T; Yazdani I
J Pak Med Assoc; 1993 Aug; 43(8):153-4. PubMed ID: 8264093
[TBL] [Abstract][Full Text] [Related]
15. Lower respiratory tract infection due to ciprofloxacin resistant Moraxella catarrhalis.
Cunliffe NA; Emmanuel FX; Thomson CJ
J Antimicrob Chemother; 1995 Jul; 36(1):273-4. PubMed ID: 8537282
[No Abstract] [Full Text] [Related]
16. The hidden impact of antibacterial resistance in respiratory tract infection. Clinical failures: the tip of the iceberg?
Garau J
Respir Med; 2001 Jun; 95 Suppl A():S5-11; discussion S26-7. PubMed ID: 11419672
[TBL] [Abstract][Full Text] [Related]
17. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
Enright MC; McKenzie H
J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
[TBL] [Abstract][Full Text] [Related]
18. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
Geddes AM
Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
Mikucka A; Janicka G; Krawiecka D; Kochanowska J
Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
[TBL] [Abstract][Full Text] [Related]
20. Only the pneumococcus..
Olson LC; Jackson MA
Pediatr Infect Dis J; 1999 Oct; 18(10):849-50. PubMed ID: 10530577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
